{
  "pmcid": "12377936",
  "sha256": "0f3ba37031d5772d5573ddd68154feeaa0ef8b743968f83cee66f776f6ef1b21",
  "timestamp_utc": "2025-11-09T15:38:56.665670+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 16.95035856573705,
    "reading_ease": 7.926138522831792,
    "word_count": 251
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 1,
        "evidence": "This retrospective study included hospitalized patients in the hemato‚Äêoncology department."
      },
      "Intervention": {
        "score": 1,
        "evidence": "Patients were evaluated for serious adverse drug reactions (ADRs) resulting from intravenous administration of AAP."
      },
      "Objective": {
        "score": 1,
        "evidence": "In this study, we aimed to identify the risk factors associated with the occurrence of serious hypotension following intravenous AAP administration during fever in patients with hematologic malignancies."
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "The serious hypotension group included 37 patients, while the control group had 111 patients randomized in a 1:3 ratio based on age and sex."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Three risk factors were identified as increasing the likelihood of serious hypotension: body temperature prior to administration, acute kidney injury, and bacteremia."
      },
      "Harms": {
        "score": 1,
        "evidence": "Patients were evaluated for serious adverse drug reactions (ADRs) resulting from intravenous administration of AAP."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 7,
    "max_score": 25
  }
}